|
 |
|
RECENT NEWS |
|
January 4, 2011
AGILE THERAPEUTICS TO PRESENT AT THE BIOTECH SHOWCASE 2011
October 26, 2010
AGILE THERAPEUTICS ANNOUNCES STUDY RESULTS DEMONSTRATING CONTRACEPTIVE PATCH AG200-15 DELIVERS A LOW DOSE OF ESTROGEN
October 18, 2010
AGILE THERAPEUTICS APPOINTS NEW PRESIDENT AND CEO AL ALTOMARI AS COMPANY PREPARES FOR COMMERCIALIZATION PHASE
October 4, 2010
AGILE THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 3 NEW CHOICE STUDY OF AG200-15, AGILE'S NOVEL, LOW-DOSE WEEKLY CONTRACEPTIVE PATCH
August 11, 2010
AGILE THERAPEUTICS COMMENCES PHASE 3 NEW CHOICE STUDY OF AG200-15, AGILE'S NOVEL, LOW-DOSE WEEKLY CONTRACEPTIVE PATCH
June 14, 2010
AGILE THERAPEUTICS SECURES $45M IN SERIES B FUNDING TO PROGRESS
LEAD CONTRACEPTIVE PATCH, AG200-15, THROUGH NDA FILING
|
ARCHIVES
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
